Table 2 Sample characteristics (dependent variables): Baseline
Variables | TOTAL (n = 44) | Men (n = 32) | Women (n = 12) | P |
|---|---|---|---|---|
Biochemical profile | ||||
- Glucose (mg/dL) | 94.1 (13.7) | 94.6 (14) | 92.7 (13.2) | 0.668 |
- HbA1c (%) | 5.4 (0.3) | 5.5 (0.3) | 5.3 (0.3) | 0.118 |
- Cholesterol (mg/dL) | 186.7 (43.4) | 182.3 (47.1) | 198.5 (30.2) | 0.224 |
- Triglycerides (mg/dL) | 131.6 (71) | 145.6 (75.7) | 94.1 (38.3) | 0.026 |
- LDH (IU/L) | 185.9 (26.9) | 185 (22.7) | 94.1 (38.3) | 0.948 |
- C-HDL (mg/dL) | 49.9 (14.1) | 45 (10.8) | 63.1 (13.9) | < 0.001 |
- C-LDL (mg/dL) | 112.1 (34.7) | 110.5 (36.9) | 116.3 (28.9) | 0.594 |
- Total cholesterol/C-HDL (mg/dL) | 3.9 (1.2) | 4.1 (1.2) | 3.2 (0.8) | 0.037 |
Anthropometric Profile | ||||
- Weight (kg) | 81.4 (17.6) | 87.6 (15) | 64.6 (12.3) | < 0.001 |
- Waist circumference (cm) | 101.9 (17) | 104.4 (18.6) | 95.2 (9.7) | 0.01 |
- BMI (kg/m2) | 28.5 (5) | 29.6 (5) | 64.6 (12.3) | 0.011 |
- WHtR | 0.6 (0.1) | 0.6 (0.1) | 0.6 (0.06) | 0.866 |
- Height (cm) | 168.5 (9.2) | 172.1 (6.2) | 158.7 (9) | 0.245 |
Cardiovascular Profile | ||||
- SBP (mmHg) | 127.2 (15) | 128.2 (14.9) | 124.5 (15.5) | 0.290 |
- DBP (mmHg) | 84.2 (10.7) | 85.4 (10.6) | 80.7 (10.5) | 0.204 |
- HR (bpm) | 84.8 (14.5) | 83.8 (16.5) | 87.5 (7.1) | 0.186 |
- Metabolic Syndrome | ||||
No | 25 (56.8%) | 16 (36.4%) | 9 (20.5%) | 0.136 |
Yes | 19 (43.2%) | 15 (36.4%) | 3 (6.8%) | |
Therapeutic Variables | ||||
- Nº of associated antipsychotic | 1.3 (0.5) | 1.3 (0.5) | 1.3 (0.5) | 0.969 |
- DDD antipsychotics (mg) | 271.4 (242.5) | 284.5 (241.1) | 236.4 (253.3) | 0.541 |